| Date | Time | Source | Headline | Symbol | Company |
| 05/15/2007 | 10:00AM | PR Newswire (US) | Vicki Higham Joins Neurobiological Technologies as Clinical Project Manager for Acute Ischemic Stroke Program | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 05/15/2007 | 10:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. (NASDAQ: NTII) Q3/07 Review Issued By Scimitar Equity Research, Inc. | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 05/09/2007 | 10:30AM | PR Newswire (US) | Neurobiological Technologies, Inc. Reports Third Quarter Results | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 05/04/2007 | 3:00PM | PR Newswire (US) | Neurobiological Technologies, Inc. to Present at the Bio 2007 Business Forum | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 05/04/2007 | 9:25AM | PR Newswire (US) | Neurobiological Technologies Inc. to Announce Third Quarter Fiscal 2007 Financial Results on May 9, 2007 and Host Conference Cal | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 05/02/2007 | 9:00AM | PR Newswire (US) | Neurobiological Technologies Reports $1.9 Million Quarterly Payment for Sales of Memantine | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 04/23/2007 | 12:00PM | Business Wire | Dutton Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained In Updated | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 04/02/2007 | 9:30AM | PR Newswire (US) | Neurobiological Technologies Announces Common Stock Offering of Approximately $7 Million | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 02/21/2007 | 8:30AM | PR Newswire (US) | Neurobiological Technologies, Inc. Appoints William A. Fletcher to the Board of Directors | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 02/20/2007 | 8:15AM | PR Newswire (US) | Neurobiological Technologies, Inc. Appoints Warren W. Wasiewski, M.D., F.A.A.P., to Vice President, Clinical Programs | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 02/13/2007 | 9:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. (NASDAQ: NTII) Q2/07 Review Issued by Scimitar Equity Research, Inc. | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 02/08/2007 | 7:00PM | PR Newswire (US) | Presentations at Stroke Conference Update Development of Viprinex(TM) (ancrod) | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 02/08/2007 | 4:51PM | PR Newswire (US) | Neurobiological Technologies, Inc Reports Second Quarter Results | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 02/06/2007 | 8:00AM | PR Newswire (US) | Neurobiological Technologies Inc. to Announce Second Quarter Fiscal 2007 Financial Results on February 8, 2007 and Host Conferen | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 01/31/2007 | 8:15AM | PR Newswire (US) | Neurobiological Technologies Receives $1.7 Million Quarterly Payment for Sales of Memantine | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 01/30/2007 | 8:30AM | PR Newswire (US) | Dawson James Securities Initiates Research Coverage on Neurobiological Technologies, Inc. (Nasdaq: NTII) with a Speculative Buy | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 01/16/2007 | 8:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. Receives $4 Million Milestone Payment From Celtic Pharma for XERECEPT(R) | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 12/07/2006 | 9:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. to Participate in Panel Discussion at the RBC Capital Markets Healthcare Conference in New Yo | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 12/04/2006 | 8:30AM | PR Newswire (US) | Neurobiological Technologies, Inc. and Nordmark Complete GMP Snake Facility in Germany for Production of Viprinex(TM) (Ancrod) | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/17/2006 | 10:17AM | PR Newswire (US) | Celtic Pharma and Neurobiological Technologies Present an Update on XERECEPT(R) for Peritumoral Brain Edema at the 11th Annual M | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/17/2006 | 10:17AM | PR Newswire (US) | Celtic Pharma and Neurobiological Technologies Present an Update on XERECEPT(R) for Peritumoral Brain Edema at the 11th Annual M | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/14/2006 | 9:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. (NASDAQ: NTII) Review Issued by Scimitar Equity Research, Inc. | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/13/2006 | 12:00PM | Business Wire | Dutton Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained in Updated | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/09/2006 | 6:11PM | PR Newswire (US) | Neurobiological Technologies, Inc. Reports First Quarter Results | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/09/2006 | 8:30AM | PR Newswire (US) | Neurobiological Technologies, Inc. Comments on Recent Stroke Trial Developments | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/07/2006 | 8:30AM | PR Newswire (US) | Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2006 | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/01/2006 | 8:45AM | PR Newswire (US) | Neurobiological Technologies, Inc. to present at the Rodman & Renshaw 8th Annual Healthcare Conference | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 10/12/2006 | 10:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. to Present at BIO InvestorForum 2006 | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 09/29/2006 | 2:13PM | PR Newswire (US) | Neurobiological Technologies Updates Status of Planned Restatement | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 08/24/2006 | 8:45AM | PR Newswire (US) | Neurobiological Technologies, Inc. Announces Completion of Targeted U.S. Site Selection for Its First Viprinex(TM) (Ancrod Inje | NASDAQ:NTII | Neurobiological Technologies (MM) |